NRC Health (NRC)
NASDAQ
20.42
+0.23 (+1.14%)
Closed
Oct 8, 2026
Day's Range
20.1120.52
52 wk Range
11.0123.68
Financial Statements - NRC - NRC Health
Revenue
137.39M▼ 4.0%
Net Income
11.60M▼ 53.2%Net Margin 8.4%
EBITDA
30.23M▼ 26.8%
Free Cash Flow
15.74M▼ 17.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 137.39M | 143.06M | 148.58M | 151.56M | 147.95M | 133.27M |
| Cost of Goods | 52.37M | 56.93M | 56.01M | 57.04M | 52.35M | 49.18M |
| Gross Profit | 85.01M | 86.12M | 92.56M | 94.51M | 95.60M | 84.09M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 22.59M | 35.19M | 40.04M | 46.54M | 50.27M | 42.14M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -95K | -34K | -41K | -2.68M | 4K | 1.11M |
| Pre Tax Income | 17.84M | 32.69M | 39.96M | 42.81M | 48.62M | 41.46M |
| Income Tax | 6.24M | 7.90M | 8.99M | 11.01M | 11.15M | 4.20M |
| Net Income | 11.60M | 24.78M | 30.97M | 31.80M | 37.46M | 37.26M |
| EPS Basic | 0.5 | 1.05 | 1.26 | 1.28 | 1.47 | 1.48 |
| EPS Diluted | 0.5 | 1.04 | 1.25 | 1.27 | 1.46 | 1.45 |
| Basic Shares Outstanding | 22.38M | 23.70M | 24.54M | 24.92M | 25.42M | 25.17M |
| Diluted Shares Outstanding | 22.38M | 23.70M | 24.54M | 24.92M | 25.42M | 25.17M |
| Ebit | 22.60M | 35.28M | 40.82M | 44.02M | 50.28M | 43.28M |
| Ebitda | 30.23M | 41.30M | 46.72M | 51.87M | 56.66M | 50.25M |
| Net Income Continuous Operations | 11.60M | 24.78M | 30.97M | 31.80M | 37.46M | 37.26M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 308K | 2K | 8K | 16K | 18K | 57K |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
